Casey Patrick John 4
4 · Legend Biotech Corp · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Legend Biotech (LEGN) Director Casey Patrick John Sells 6,000 Shares
What Happened
Casey Patrick John, a director of Legend Biotech Corp (LEGN), sold 6,000 ordinary shares on 2026-06-30 at $14.80 per ordinary share, generating $88,800 in proceeds. The sale is reported as an open-market/private sale (code S).
Key Details
- Transaction date: 2026-06-30. Report filed: 2026-07-02 (no late filing indicated from provided data).
- Price: $14.80 per ordinary share (equivalent to $29.60 per ADS after conversion). Total proceeds: $88,800.
- Shares owned after transaction: Not specified in the provided summary of the Form 4.
- Footnotes: F1 — Ordinary shares may be represented by American Depositary Shares (ADSs); F2 — the column price reflects the ADS-converted price of $29.60 per ADS (2 ordinary shares per ADS).
- No 10b5-1 plan, tax-withholding, or other special conditions were indicated in the provided transaction details.
Context
This was a straightforward sale (disposition) by a company director. Sales are common and can reflect many personal reasons; they are generally less informative about company outlook than purchases. The filing clarifies ADS/ordinary-share conversion so retail investors see the equivalent ADS price.
Insider Transaction Report
Form 4
Casey Patrick John
Director
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-06-30$14.80/sh−6,000$88,800→ 48,604 total
Footnotes (2)
- [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
- [F2]The price reported in Column 4 represents the converted sales price of ADSs of $29.60 per ADS (which is equivalent to $14.80 per ordinary share).
Signature
/s/ James Pepin, Attorney-in-Fact|2026-07-02